Linee Guida / Raccomandazioni SIR
| PATOLOGIA | CRITERI/ RACCOMANDAZIONI |
DATA | NOME | LINK |
|---|---|---|---|---|
| ARTRITE PSORIASICA | SIR | 2017 | Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology | link |
| ARTRITE PSORIASICA | SIR | 2011 | Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology | link |
| ARTRITE PSORIASICA | SIR | 2006 | Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis | link |
| ARTRITE PSORIASICA | SIR | 2004 | Raccomandazioni per il corretto uso degli agenti biologici bloccanti il TNFa nel trattamento dell’artrite psoriasica | link |
| ARTRITE REUMATOIDE | SIR | 2019 | Italian consensus recommendations for the management of hepatitis c infection in patients with rheumatoid arthritis | link |
| ARTRITE REUMATOIDE | SIR | 2019 | The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis | link |
| ARTRITE REUMATOIDE | SIR | 2011 | Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology. I. Efficacy | link |
| ARTRITE REUMATOIDE | SIR | 2011 | Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology. II. Safety | link |
| ARTRITE REUMATOIDE | SIR | 2006 | Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy. | link |
| ARTRITE REUMATOIDE | SIR | 2004 | Linee guida per la diagnosi precoce e la terapia dell’Artrite Reumatoide | link |
| ARTROSI | SIR | 2004 | Consensus italiana sulle raccomandazioni dell’EULAR 2003 per il trattamento dell’artrosi del ginocchio | link |
| ARTROSI | SIR | 2006 | Italian consensus on EULAR recommendations 2005 for the management of hip osteoarthritis | link |
| FIBROMIALGIA | SIR | 2021 | The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia best practices based on current scientific evidence | link |
| GOTTA | SIR | 2019 | The Italian Society of Rheumatology clinical practice guidelines for the diagnosis and management of gout | link |
| GOTTA | SIR | 2013 | Italian Society of Rheumatology recommendations for the management of gout | english link link italiano |
| OSTEOARTRITI | SIR | 2019 | The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis | link |
| OSTEOARTRITI | SIR | 2013 | Italian Society for Rheumatology recommendations for the management of hand osteoarthritis | english link link italiano |
| POLIMIALGIA REUMATICA | SIR | 2020 | The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica | english link |
| SPONDILITE ANCHILOSANTE | SIR | 2003 | Raccomandazioni per l’inizio della terapia con anti TNF-a in pazienti con spondilite anchilosante | link |
| SPONDILOARTRITI | SIR | 2021 | The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis | link |
| VASCULITI | SIR / ISS | 2021 | Le linee guida per la pratica clinica della Società Italiana di Reumatologia sulla diagnosi e sul trattamento delle vasculiti dei grossi vasi | link |
| VASCULITI | SIR | 2012 | Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agent | link |
| ALTRE CONDIZIONI | SIR | 2007 | Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis. | link |
| ALTRE CONDIZIONI | SIR | 2011 | Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use | link |